Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ATAI
ATAI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ATAI News
AtaiBeckley Provides 2026 Outlook with Accelerated Drug Development Plans
Jan 08 2026
Globenewswire
GH Research Secures FDA Clearance for GH001 Clinical Trial
Jan 05 2026
Benzinga
Organigram Expands Investment in Phylos to $10 Million for Cannabis Genetics
Jan 04 2026
Yahoo Finance
AtaiBeckley Completes Redomiciliation from Netherlands to U.S.
Dec 31 2025
Globenewswire
AtaiBeckley Completes Redomiciliation from Netherlands to U.S.
Dec 31 2025
Newsfilter
AtaiBeckley Joins NASDAQ Biotechnology Index, Strengthening Market Position
Dec 23 2025
Globenewswire
Psychedelic Stocks May Gain from Marijuana Rescheduling, According to Jefferies
Dec 19 2025
SeekingAlpha
Atai Life Sciences N.V. (ATAI) Obtains Patent for Treatment of Social Anxiety Disorder
Dec 18 2025
Yahoo Finance
AtaiBeckley Secures New Patent for EMP-01, Ensuring Exclusivity Until 2043
Dec 11 2025
Newsfilter
Enhanced Strengthens Executive Leadership Team and Board of Directors
Nov 20 2025
Newsfilter
AtaiBeckley to Attend the Jefferies Global Healthcare Conference in London
Nov 13 2025
Newsfilter
Tech Selloff Weakens Key S&P 500 Support — Here's When Stocks May Truly Decline
Nov 07 2025
MarketWatch
Stock Investors Enter November Grateful for a Generous Market
Oct 30 2025
MarketWatch
October's Conclusion Typically Brings Profitable Opportunities for Stock Investors
Oct 23 2025
MarketWatch
Analysts' Predictions for the Future of ATAI Life Sciences
Oct 22 2025
Benzinga
Canaccord Genuity Reaffirms Buy Rating on ATAI Life Sciences and Increases Price Target to $14
Oct 22 2025
Benzinga
Show More News
